Pune, India -- (SBWire) -- 10/04/2016 --TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Protein Kinase Receptor R4 or Transforming Growth Factor Beta Receptor Type I or ALK5 or TGFBR1 or EC 2.7.11.30) - Pipeline Review, H2 2016', provides in depth analysis on TGF Beta Receptor Type 1) targeted pipeline therapeutics.
TGF Beta Receptor Type 1 – Pipeline Review, H2 2016, provides an overview of the TGF Beta Receptor Type 1 pipeline landscape. The report provides comprehensive information on the therapeutics under development for TGF Beta Receptor Type 1 , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Browse more detail information about TGF Beta Receptor Type 1 at: http://www.absolutereports.com/10351056
The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for TGF Beta Receptor Type 1 and features dormant and discontinued projects.
Key players in TGF Beta Receptor Type 1 – Pipeline Review, H2 2016:
-Eli Lilly and Company
-SK Chemicals Co., Ltd.
-Yuhan Corporation
Get a PDF Sample of TGF Beta Receptor Type 1 Market Research Report at: http://www.absolutereports.com/enquiry/request-sample/10351056
Drug Profiles of Included in TGF Beta Receptor Type 1 Therapeutics Development Market Report
-Kinase Receptor R4 or Transforming Growth Factor Beta Receptor Type I or ALK5 or TGFBR1 or EC 2.7.11.30)
-Galunisertib
-Monoclonal Antibodies to Antagonize TGF-Beta Receptor Type-1 for HCV associated Liver Fibrosis
-NOV-1301
-SKI-2162
-Small Molecule to Inhibit TGF Beta Receptor Type 1 for Solid Tumor
-Small Molecule to Inhibit TGF-beta Receptor Type 1 for Hepatitis C
-SRI-011381
-TEW-7197
-YH-14618
-YH-14619
And other drug profiles
Have any query? ask our expert @ http://www.absolutereports.com/enquiry/pre-order-enquiry/10351056
List of Figures of TGF Beta Receptor Type 1 Therapeutics Market Included:
- Number of Products under Development for TGF Beta Receptor Type 1, H2 2016
- Number of Products under Development for TGF Beta Receptor Type 1 -Comparative Analysis, H2 2016
- Number of Products under Development by Companies, H2 2016
- Number of Products under Investigation by Universities/Institutes, H2 2016
- Comparative Analysis by Clinical Stage Development, H2 2016
- Comparative Analysis by Early Stage Products, H2 2016
- Assessment by Monotherapy Products, H2 2016
- Number of Products by Top 10 Targets, H2 2016
- Number of Products by Stage and Top 10 Targets, H2 2016
- Number of Products by Top 10 Mechanism of Actions, H2 2016
- Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016
- Number of Products by Top 10 Routes of Administration, H2 2016
- Number of Products by Stage and Top 10 Routes of Administration, H2 2016
- Number of Products by Top 10 Molecule Types, H2 2016
- Number of Products by Stage and Top 10 Molecule Types, H2 2016
Get Discount on TGF Beta Receptor Type 1 Market Research Report at: http://www.absolutereports.com/enquiry/request-discount/10351056
Scope of TGF Beta Receptor Type 1 Pipeline Review Report-
– The report provides a snapshot of the global therapeutic landscape of TGF Beta Receptor Type 1
– The report reviews pipeline therapeutics for TGF Beta Receptor Type 1 by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
About Absolute Report
Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.
Contact
Mr. Ameya Pingaley
Absolute Reports
408-520-9750
Email – sales@absolutereports.com
www.absolutereports.com
TGF Beta Receptor Type 1 Therapeutic Pipeline Review H2 2016, Drug Profile and Major Key Players Analysis
The TGF Beta Receptor Type 1 - Pipeline Review, H2 2016 report provides a snapshot of the global therapeutic landscape for TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Protein Kinase Receptor R4 or Transforming Growth Factor Beta Receptor Type I or ALK5 or TGFBR1 or EC 2.7.11.30)